Zikani Therapeutics, Inc. — Form D/A
Zikani Therapeutics, Inc. of Watertown, MA, a company, filed a Form D amendment with the SEC on 2016-04-29. The offering totals $27.8M, of which $12.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-04-29
- Form: D/A
- Accession: 0001634953-16-000004
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $27.8M
- Amount sold: $12.2M
- Remaining: $15.6M
- Investors: 10
- Date of first sale: 2015-02-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-234735
Issuer
- Name: Zikani Therapeutics, Inc.
- CIK: 0001634953
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 480 Arsenal St., Ste. 130, Watertown, MA, 02472
- Phone: 617-229-6503
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| Fereydoun G Firouz | Director | WATERTOWN, MA |
| Vikas G Goyal | Director | WATERTOWN, MA |
| Lawrence Miller | Director | Aston, PA |
| Andrew G Myers | Director | WATERTOWN, MA |
| Raj G Parekh | Director | WATERTOWN, MA |
| Monique G Sciersing | Director | WATERTOWN, MA |
| Henry G Skinner | Director | WATERTOWN, MA |
| Andrew G Littlehale | Executive Officer | WATERTOWN, MA |
| Lawrence Miller | Executive Officer | Aston, PA |
| ANDREW MYERS | Director | SAN FRANCISCO, CA |
| Mary Szela | Director | Westminster, CO |
| Raj Parekh | Director | Waltham, MA |
| Sumit Aggarwal | Director | Watertown, MA |
| Sumit Aggarwal | Executive Officer | Watertown, MA |
| Christopher A Viehbacher | Director | Watertown, MA |
| Raj B Parekh, Ph.D. | Director | Watertown, MA |
| Anja Harmeier | Director | Boston, MA |
| Christopher Viehbacher | Director | Cambridge, MA |
| HENRY SKINNER | Director | SAN DIEGO, CA |
| Vikas Goyal | Director | Boston, MA |
| Markus Goebel | Director | Sunnyvale, CA |
| Joseph Zakrzewski | Director | Watertown, MA |
| Edward Mascioli | Executive Officer | Watertown, MA |
Other filings by this issuer (3)
More